CadmiumCD, LLC – Trademark Portfolio

Entity Type: 16

CadmiumCD, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CADMIUMCD, EVENTSCRIBE, and CONFERENCE PASSPORT. The owner is based in Forest Hill, MD.

19 Newport Drive, Ste. 101

Forest Hill, MD 21050

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CadmiumCD, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does CadmiumCD, LLC have?

CadmiumCD, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does CadmiumCD, LLC file in?

CadmiumCD, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CadmiumCD, LLC's most well-known trademarks?

CadmiumCD, LLC's registered trademark portfolio includes well-known marks such as CADMIUMCD, EVENTSCRIBE, and CONFERENCE PASSPORT. These are among 3 currently registered trademarks in the portfolio.

What is CadmiumCD, LLC's trademark registration success rate?

CadmiumCD, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.